Wu Tsai Neurosciences Institute


Showing 41-50 of 59 Results

  • David A. Spain, MD

    David A. Spain, MD

    David L. Gregg, MD Professor of General Surgery

    Current Research and Scholarly InterestsOur main areas of interest are
    1. clinical research in trauma and critical illness
    2. economics of this care
    3. PTSD and stress response after critical injury or illness

  • David Spiegel

    David Spiegel

    Jack, Lulu and Sam Willson Professor of Medicine

    Current Research and Scholarly InterestsDr. Spiegel's research program involves mind/body interactions, including cancer progression, the response to traumatic stress, and the effect of hypnosis on the perception of pain and anxiety.

  • Daniel Spielman

    Daniel Spielman

    Professor of Radiology (Radiological Sciences Lab) and, by courtesy, of Electrical Engineering

    Current Research and Scholarly InterestsMy research interests are in the field of medical imaging, particularly magnetic resonance imaging and in vivo spectroscopy. Current projects include MRI and MRS at high magnetic fields and metabolic imaging using hyperpolarized 13C-labeled MRS.

  • Konstantina M. Stankovic, MD, PhD, FACS

    Konstantina M. Stankovic, MD, PhD, FACS

    Bertarelli Foundation Professor and Professor of Otolaryngology - Head & Neck Surgery (OHNS) and, by courtesy, of Neurosurgery

    Current Research and Scholarly InterestsOur investigative efforts are organized along 3 research thrusts:
    1. Vestibular schwannoma: uncovering mechanisms of sensorineural hearing loss (SNHL) and identifying better therapies;
    2. High-resolution imaging of the inner ear;
    3. Novel sensing of and therapies for SNHL.
    Given the complex, multifaceted nature of these problems, our approach to them involves domain-specific customization and fusion of tools from molecular biology, systems neuroscience, biotechnology and otologic surgery.

  • Creed Stary

    Creed Stary

    Associate Professor of Anesthesiology, Perioperative and Pain Medicine (Adult MSD) and, by courtesy, of Ophthalmology

    Current Research and Scholarly InterestsMechanisms promoting neuronal survival following cerebral ischemia-reperfusion injury; utilizing microRNA's to target multiple pathways to promote mitochondrial homeostasis and cell survival; anesthetic neurotoxicity; astrocyte-neuronal interaction

  • Kristen K. Steenerson, MD

    Kristen K. Steenerson, MD

    Clinical Assistant Professor, Otolaryngology (Head and Neck Surgery)
    Clinical Assistant Professor, Neurology & Neurological Sciences

    BioKristen Steenerson is a board-certified neurologist with fellowship training in otoneurology. After graduating cum laude from Claremont McKenna College where she was honored as an All-American lacrosse defensive player, she continued on to medical school at the University of Utah in Salt Lake City, Utah. After four years of excellent training and annual ski passes, she proceeded to the Mayo Clinic in Arizona for neurology residency. There, she discovered the beauty of the Sonoran Desert as well as an unmet need in balance disorders and vertigo, motivating her to pursue a fellowship in otoneurology at Barrow Neurological Institute. She joins Stanford with positions in both Otolaryngology--Head and Neck Surgery and Neurology with the goal of jointly addressing the junction of inner ear and brain disorders. Her specific interests include vestibular migraine, benign paroxysmal positional vertigo, Ménière's disease and international neurology.

  • Marcia L. Stefanick, Ph.D.

    Marcia L. Stefanick, Ph.D.

    Professor (Research) of Medicine (Stanford Prevention Research Center), of Obstetrics and Gynecology and, by courtesy, of Epidemiology and Population Health

    Current Research and Scholarly InterestsMarcia L. Stefanick, Ph.D is a Professor of Medicine Professor of Obstetrics and Gynecology, and by courtesy, Professor of Epidemiology and Population Health at Stanford University School of Medicine. Dr. Stefanick’s research focuses on chronic disease prevention (particularly, heart disease, breast cancer, osteoporosis, and dementia) in both women and men. She is currently the Principal Investigator the Women’s Health Initiative (WHI) Extension Study, having been the PI of the Stanford Clinical Center of the landmark WHI Clinical Trials and Observational Study since 1994 and Chair of the WHI Steering and Executive Committees from 1998-2011, as well as PI of the WHI Strong and Healthy (WHISH) Trial which is testing the hypothesis that a DHHS-based physical activity intervention, being delivered to a multi-ethnic cohort of about 24,000 WHI participants across the U.S., aged 68-99 when the trial started in 2015, will reduce major cardiovascular events over 8 years, compared to an equal number of “usual activity” controls. Dr. Stefanick is also PI of the Osteoporotic Study of Men (MrOS) which is continuing to conduct clinical assessments of bone and body composition in survivors of an original cohort of nearly 6000 men aged 65 and over in 2001. As founding Director of the Stanford Women’s Health and Sex Differences in Medicine (WHSDM, “wisdom”) Center, she plays a major role in promoting research and teaching on Sex and Gender in Human Physiology and Disease, Women’s Health and Queer Health and Medicine. Dr. Stefanick also plays major leadership roles at the Stanford School of Medicine, including as co-leader of the Population Sciences Program of the Stanford Cancer Institute, Stanford’s NCI-funded comprehensive cancer center.

    Dr. Stefanick obtained her B.A. in biology from the University of Pennsylvania, Philadelphia, PA (1974), then pursued her interest in hormone and sex difference research at the Oregon Regional Primate Research Center, after which she obtained her PhD in Physiology at Stanford University, focusing on reproductive physiology and neuroendocrinology, with exercise physiology as a secondary focus. Her commitment to human research led to a post-doctoral fellowship in Cardiovascular Disease Prevention at the Stanford Prevention Research Center, which has been her academic home for nearly 40 years.

  • Gary K. Steinberg, MD, PhD

    Gary K. Steinberg, MD, PhD

    Bernard and Ronni Lacroute-William Randolph Hearst Professor of Neurosurgery and Neurosciences and Professor, by courtesy, of Neurology

    Current Research and Scholarly InterestsOur laboratory investigates the pathophysiology and treatment of cerebral ischemia, and methods to restore neurologic function after stroke. Treatment strategies include brain hypothermia, stem cell transplantation and optogenetic stimulation. Our clinical research develops innovative surgical, endovascular and radiosurgical approaches for treating difficult intracranial aneurysms, complex vascular malformations and occlusive disease, including Moyamoya disease, as well as stem cell transplant.

  • Lawrence Steinman, MD

    Lawrence Steinman, MD

    George A. Zimmermann Professor and Professor of Pediatrics

    Current Research and Scholarly InterestsOur laboratory is dedicated to understanding the pathogenesis of autoimmune diseases, particularly multiple sclerosis. We have developed several new therapies for autoimmunity, including some in Phase 2 clinical trials, as well as one approved drug, natalizumab. We have developed microarray technology for detecting autoantibodies to myelin proteins and lipids. We employ a diverse range of molecular and celluar approaches to trying to understand multiple sclerosis.

  • Lars Steinmetz

    Lars Steinmetz

    Dieter Schwarz Foundation Endowed Professor and Professor of Genetics

    Current Research and Scholarly InterestsWe apply diverse genomic approaches to understand how genetic variation affects health and disease by: 1) functional and mechanistic analyses of gene regulation, 2) studies of meiotic recombination and inheritance, 3) analyses of genetic and environmental interactions, and 4) characterization of diseases in human cells and model organisms. We integrate wet lab and computational genomic, transcriptomic, proteomic and metabolic approaches, and develop technologies to enable personalized medicine.